Ruby Williams, M.D. Drugs, Alcohol and Sleep February 24, 2018

Size: px
Start display at page:

Download "Ruby Williams, M.D. Drugs, Alcohol and Sleep February 24, 2018"

Transcription

1

2 Ruby Williams, M.D. Drugs, Alcohol and Sleep February 24, 2018

3 Objectives Describe pharmacology of commonly prescribed drugs for stimulants and hypnotics Brief review of common drugs that affect sleep and by the manner of how they do it either by Inducing sleepiness Inducing insomnia Sleep related side effects (ie RLS, EEG changes and parasomnias Brief review of how alcohol affects our sleep

4 Sleep and Neurotransmitters Wake Neurotransmitters Dopamine Norepinephrine Serotonin Acetycholine Histamine Orexin Sleep Neurotransmitters Adenosine Gaba

5 Stimulants Amphetamines Inhibit reuptake of dopamine and release presynaptic vesicles containing NE Leads to more wakefulness, less REM and SWS Bruxism, cardiovascular symptoms Methylphenidates Prevents reuptake of dopamine but does not release Less crash effect Modafinil Thought to be related to dopamine transport inhibition

6 Drug Comparison adderall Ritalin Provigil Nuvigil

7 Caffeine Adenosine: Increases as the day increases eventually stimulating sleepiness Caffeine: Antagonizes adenosine receptors Average person needs 200mg to have an effect

8 Benzo-like Drugs Act on GABA receptors Preferred over benzos less tolerance Decreases TST and sleep latency No clear change in sleep architecture and staging Possible increased sleep spindles SE Amnesia, non REM parasomnias (sleep eating), hallucinations Few respiratory effects

9 Sonata Ambien Lunesta

10 Benzodiazepams Modify GABA receptor to potentiate GABA effects Decrease sleep latency and WASO, Inc d TST Decrease REM sleep, Increase N2 Frequent spindles during N2 Suppresses N3 sleep Noteable side effects in the elderly Increased falls in elderly Tolerance and rebound/insomnia Mild respiratory depression

11

12 Other Sleep Aides Melatonin Naturally made in the pineal gland Decreases SL 4min and Sleep efficiency 2% Ramelteon Melatonin antagonist, low abuse FDA approved Mild improvement in TST and sleep latency Tasimelteon FDA approved for Non-24hr sleep wake d/o Suvorexant Orexin receptor antagonist FDA approved, decreases sleep latency and WASO Absolutely contraindicated in Narcolepsy

13 Tricyclic Antidepressants Serotonin and NE reuptake inhibition Muscarinic and histamine antagonist Decrease REM sleep Increase PLMs and RLS symptoms Sedating TCAs (anticholinergic/antihistamine) Decrease TST and sleep latency Amitriptyline, imipramine, doxepin Adrenergic TCAs May increase awakenings and decrease TST Nortriptyline

14 MAOI Monoamine oxidase inhibitors: prevent dopamine, serotonin and norepinephrine Side effects are daytime sleepiness and insomnia Marked decreased REM sleep

15 SSRI Selective serotonin reuptake inhibitor Decreased TST, Increased WASO, increased sleep latency Decreased REM, increased stage 1 Increased PLMS REM sleep w/o atonia Prozac eyes on EOG

16

17 Most stimulating: Prozac fluoxetine Zoloft- sertraline Paxil- paroxetine celexa- citalopram Lexapro- escitalopram Luvox-fluvoxamine Most sedating

18 SNRIs Serotonin and norepinephrine reuptake inhibitors Venlafaxine- Effexor Duloxetine- Cymbalta Multiple uses Pain- fibro or neuropathic, depression, anxiety Insomnia very common Watch when this medication is dosed! Dec d TST, Dec d REM, Inc d PLMs, Reports of RBD

19 Trazodone Serotonin antagonist and reuptake inhibitors Drowsiness is a SE and often used as a hypnotic Dec d SL, Inc d SWS, No change in REM Does not effect PLM or REM SE unwanted prolonged priapism

20 Buproprion Wellbutrin Inhibits dopamine and NE reuptake Does not really affect REM sleep Dec s PLMS Insomnia (consider depression with EDS)

21 Mirtazapine Antagonizes 5HT-2 and HT1 receptors Highly sedating Dec d sleep latency and inc d N3 Daytime sleepiness is a SE could use for insomnia RLS can get worse

22 Antipsychotics Multiple mechanisms Dopamine, 5HT, Ach, Histamine Sedating Inc TST and dec SL Inc SWS and dec REM Exacerbate RLS

23 Other Drugs Buspirone 5HT1-A partial agonist Non sedating anxiolytic Dec d REM sleep Donepizil Causes vivid dreams Insomnia due to increased cholinergic activity

24 Beta Blockade Common drug that can affect sleep Daytime fatigue, nightmares, insomnia Impairs melatonin production Propanolol is most associated with sleep disruption The more lipophilic the drug, the more sleep side effects

25 Alpha-2 Agonists Clonidine and methyldopa Sedation very common Usually goes away with time Nightmares and insomnia

26 Prazosin Alpha-1 antagonist Inc TST and increased REM sleep Reduces nightmares (key use) Great for PTSD related nightmares

27 Antihistamines H1 antagonists Benadryl (diphenhydramine),hydroxyzine Lipophilic and crosses blood barrier very easily Certrizine (Zyrtec) and loratadine (Claritin) hydrophilic thus less sedating

28 Opiates Very decreased amount of N3 sleep No clear effect on TST, however, in chronic users may lead to increase WASO Decreased respiratory drives especially at higher doses Can lead central sleep apneas Can lead to hypercapnia and hypoxia

29 Respiratory Drugs Prednisone Insomnia with increased doses, dec REM Pseudophedrine Insomnia Theophyline Insomnia and WASO Short acting beta agonists Insomnia

30 Alcohol and Sleep

31 Alcohol Alcohol-Related Deaths: An estimated 88,000 8 people (approximately 62,000 men and 26,000 women 8 ) die from alcohol-related causes annually, making alcohol the third leading preventable cause of death in the United States. The first is tobacco, and the second is poor diet and physical inactivity. 9 In 2014, alcohol-impaired driving fatalities accounted for 9,967 deaths (31 percent of overall driving fatalities). 10

32 Alcohol and Sleep Physiology Patient s given alcohol 30-60min before bedtime Effect: patient s blood alcohol content peaked at lights out Dose ranged from gram per kilogram of body weight 1 Corresponded to 1-6 standard drinks 2 leading to breath alcohol of WILLIAMS, H., AND SALAMY, A. Alcohol and sleep. In: Kissin, B., and Begleiter, H., eds. The Biology of Alcoholism. New York: Plenum Press, pp A standard drink is defined as one 12-ounce bottle of beer or wine cooler, one 5-ounce glass of wine, and 1.5 ounces of 80 proof distilled spirits

33 Findings: Consistently effects the proportions of various sleep stages 1. Dose dependent suppression of REM sleep at the first half of the sleep period 1 Development o f REM rebound 2 during the second half of the night Overall amount of REM sleep in subjects receiving alcohol before sleep did not differ from subjects who did not drink alcohol 1 This was associated with the completed alcohol metabolism and elimination from the body 1 Increase in slow wave sleep with acute ingestion during first half of sleep 1

34 Recurrent ingestion after 3 nights led to tolerance of alcohol s sedative and sleep stage effects 1 The percentage of SWS and REM returned to normal The discontinuation of nightly alcohol led to REM rebound 1

35 PSG Effects Acute alcohol ingestion: First part of sleep: dec SOL & WASO, inc REM SL, dec REM Second part of sleep: inc WASO, dec N3, Inc REM Alcohol withdrawal: Inc SOL, Inc WASO, Dec TST, Dec N3, Dec REM SL and Inc REM (REM Rebound) Alcohol abstinence: Inc SOL, Dec TST, Inc WASO, Dec N3 (may be forever in alcoholics who remain sober)

36 Alcohol and OSA Acute ingestion can make snoring and AHI worse Decreased REM sleep in first part of the night decreases the longer events associated with REM sleep however, more severe desaturations and presumably longer events can occur the second part of the night

37 Alcohol and Sleep Disturbances Alcohol use: Inc nightmares and vivid dreams. Inc enuresis, RLS, sleep terrors/sleep walking, snoring and osa Acute alcohol withdrawal: Insomnia, frequent awakenings accompanied by headaches and diaphoresis. Vivid disturbing dreams. Alcohol abstinence: Sleep disturbance, including insomnia, can persist for several years. Dec TST with delirium tremens.

38 Relation to nocturnal sleep to daytime alertness In one study, young pilots drank alcohol between 6 p.m. and 9 p.m. in quantities sufficient to result in blood alcohol concentrations (BACs) of 0.10 and 0.12 percent right before bedtime. 1 The following morning, more than 14 hours after consuming alcohol and with BACs at 0, the performance of pilots in a flight simulator was impaired relative to their performance after consuming a placebo 1 Roehrs and colleagues gave studies alcohol before bedtime, goal of breath 0.06, and studied their performance the next day on MSLT checking their auditory vigilance, in which the participants had to respond to a certain sound, or divided attention tasks, in which the participants had to perform two tasks simultaneously 2 Alertness and divided attention was decreased, showing that alcohol indirectly affects daytime performance by affecting sleep. 2

39 Bottom Line About Alcohol Makes you feel good when you re drinking it, but you will pay for it later with: Exacerbation of snoring Sleep disturbances with second half of the night REM rebound Exacerbation of OSA Increased WASO Poor performance next day

Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD

Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD Drugs, Sleep & Wakefulness Brian Koo Reena Mehra MD MS Kingman Strohl MD Things To Keep In Mind Many drugs effect sleep either causing insomnia or sedation Disruption of sleep and wakefulness may not be

More information

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines

More information

BRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S.

BRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S. BRIEF ANTIDEPRESSANT OVERVIEW Casey Gallimore, Pharm.D., M.S. Antidepressant Medication Classes First Generation Tricyclic Antidepressants (TCAs) Monoamine Oxidase Inhibitors (MAOIs) Second Generation

More information

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally

More information

Disclosure. Objective 1. Objective 2. Naval Health Center New England. Objective 3. APNA 27th Annual Conference Session 1036: October 9, 2013

Disclosure. Objective 1. Objective 2. Naval Health Center New England. Objective 3. APNA 27th Annual Conference Session 1036: October 9, 2013 Understanding Sleep and Antidepressants: Lessons from Research Literature and Clinical Practice Joseph M. Holshoe, PMHNP-BC Commander, U.S. Public Health Service Behavioral Health Consultant, Primary Care

More information

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty

More information

Treating sleep disorders

Treating sleep disorders Treating sleep disorders Sue Wilson Centre for Neuropsychopharmacology Imperial College London sue.wilson@imperial.ac.uk Suggested algorithm for treatment of insomnia Diagnosis of insomnia Associated with

More information

Insomnia: Updates in Medical Management. Michael Newnam M.D.

Insomnia: Updates in Medical Management. Michael Newnam M.D. Insomnia: Updates in Medical Management Michael Newnam M.D. Sleep Neurobiology Delicate balance of excitatory and inhibitory neurotransmitters that control the switch between wakefulness and sleep Circadian

More information

DRUGS THAT ACT IN THE CNS

DRUGS THAT ACT IN THE CNS DRUGS THAT ACT IN THE CNS Anxiolytic and Hypnotic Drugs Dr Karamallah S. Mahmood PhD Clinical Pharmacology 1 OTHER ANXIOLYTIC AGENTS/ A. Antidepressants Many antidepressants are effective in the treatment

More information

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.

More information

Diagnosis and treatment of sleep disorders

Diagnosis and treatment of sleep disorders Diagnosis and treatment of sleep disorders Normal human sleep Sleep cycle occurs about every 90 minutes, approximately 4-6 cycles occur per major sleep episode NREM (70-80%) slow wave sleep heart rate,

More information

INSOMNIA IN THE GERIATRIC POPULATION. Shannon Bush, MS4

INSOMNIA IN THE GERIATRIC POPULATION. Shannon Bush, MS4 INSOMNIA IN THE GERIATRIC POPULATION Shannon Bush, MS4 CHANGES IN SLEEP ARCHITECTURE 2 Reduction in slow wave sleep (stage 3 and 4) Increase in lighter stages of sleep (stage 1 and 2) Decrease in REM sleep

More information

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM. Autism Spectrum Disorder Cynthia King, MD Associate Professor of Psychiatry UNMSOM Autism Spectrum Disorder 1 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive

More information

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM

3/19/2018. Cynthia King, MD Associate Professor of Psychiatry UNMSOM Cynthia King, MD Associate Professor of Psychiatry UNMSOM 1 2 Autism Spectrum Disorder 3 Identify three behavioral health concerns in ASD Identify three common families of medication that may be supportive

More information

PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES

PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES PHYSICIAN REFERENCE ANTIDEPRESSANT DOSING GUIDELINES Table of Contents Print TABLE OF CONTENTS Drug Page Number Anafranil... 2 Asendin... 4 Celexa... 4 Cymbalta... 6 Desyrel... 8 Effexor...10 Elavil...14

More information

Anti-Depressant Medications

Anti-Depressant Medications Anti-Depressant Medications A Introduction: This topic may be a little bit underestimated here in Jordan, while in western countries it has more significance. The function of anti-depressants is to change

More information

Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D.

Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D. Prepared by: Elizabeth Vicens-Fernandez, LMHC, Ph.D. Sources: National Institute of Mental Health (NIMH), the National Alliance on Mental Illness (NAMI), and from the American Psychological Association

More information

Available Strengths Limits. 200 mg tablets PA. 50 mg, 150 mg, 200 mg, 250 mg tablets. 500 mg/ml solution PA

Available Strengths Limits. 200 mg tablets PA. 50 mg, 150 mg, 200 mg, 250 mg tablets. 500 mg/ml solution PA MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY Sleeping Disorders P&T DATE: 12/14/2016 THERAPEUTIC CLASS Psychiatric Disorders REVIEW HISTORY: 2/16, 5/15, 2/12 LOB AFFECTED

More information

Quick Guide to Common Antidepressants-Adults

Quick Guide to Common Antidepressants-Adults Quick Guide to Common Antidepressants-Adults Medication Therapeutic Range (mg/day) Initial Suggested Serotonin Reuptake Inhibitors (SSRIs) All available as generic FLUOXETINE (Prozac) CITALOPRAM (Celexa

More information

Insomnia. Dr Terri Henderson MBChB FCPsych

Insomnia. Dr Terri Henderson MBChB FCPsych Insomnia Dr Terri Henderson MBChB FCPsych Plan Basics of insomnia Pharmacology Medication CBT Details of insomnia Unsatisfactory sleep that impairs daytime well-being Starts with specific problem or change

More information

Antidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry

Antidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free

More information

ANTI-DEPRESSANT MEDICATIONS

ANTI-DEPRESSANT MEDICATIONS ANTI-DEPRESSANT MEDICATIONS This information is not intended to be a substitute for medical advice. It s purpose is solely informative. If your client or yourself are taking antidepressants, do not change

More information

Parkinson s Disease Associated Sleep Disturbance Ehsan M. Hadi, MD, MPH. Dignity Health Neurological Institute

Parkinson s Disease Associated Sleep Disturbance Ehsan M. Hadi, MD, MPH. Dignity Health Neurological Institute Parkinson s Disease Associated Sleep Disturbance Ehsan M. Hadi, MD, MPH. Dignity Health Neurological Institute Parkinson s Disease 2 nd most common neurodegenerative disorder Peak age at onset is 60 years

More information

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic

More information

Index. baclofen 73 basal forebrain nuclei 174

Index. baclofen 73 basal forebrain nuclei 174 Index acetazolamide 33 acetylcholine esterase inhibitor 174 actigraphy 14 activity meter 226 acute insomnia 4 α1 adrenergic activity 88 α 1 containing receptor 211 adenosine 108 advanced sleep phase syndrome

More information

Treating Depression in Adults

Treating Depression in Adults Treating Depression in Adults By Deborah Christensen, Ph.D., M.S.C.P. Depressive Disorders represent a broad and heterogeneous group of commonly diagnosed psychological disorders. The DSM adequately describes

More information

Insomnia. St. Joseph s Annual Family Practice Refresher March 1, Robert J. Ostrander, M.D

Insomnia. St. Joseph s Annual Family Practice Refresher March 1, Robert J. Ostrander, M.D St. Joseph s Annual Family Practice Refresher March 1, 2018 Robert J. Ostrander, M.D If in bed I say, When shall I arise? then the night drags on; I am filled with restlessness until the dawn. Job 7:4

More information

Depression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms

Depression and Anxiety. What is Depression? What is Depression? By Christopher Okiishi, MD Spring Not just being sad A syndrome of symptoms Depression and Anxiety By Christopher Okiishi, MD Spring 2016 What is Depression? Not just being sad A syndrome of symptoms Depressed mood Sleep disturbance Decreased interest in usual activities (anhedonia)

More information

Change Your Brain, Change Your Life. The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness

Change Your Brain, Change Your Life. The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness Change Your Brain, Change Your Life The Breakthrough Program for Conquering Anxiety, Depression, Obsessiveness, Anger, and Impulsiveness Daniel G Amen Three Rivers Press New York Appendix Medication 1.

More information

Management of SSRI Induced Sexual Dysfunction. Serotonin Reuptake Inhibitors*

Management of SSRI Induced Sexual Dysfunction. Serotonin Reuptake Inhibitors* Management of SSRI Induced Sexual Dysfunction John J. Miller, M.D. Medical Director, Center for Health and WellBeing Exeter, NH Serotonin Reuptake Inhibitors* fluoxetine clomipramine sertraline paroxetine

More information

Presentation is Being Recorded

Presentation is Being Recorded Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please

More information

Medications Guide: Public Speaking And Social Anxiety

Medications Guide: Public Speaking And Social Anxiety AnxietyHub.org Dr. Cheryl Mathews Medications Guide: Public Speaking And Social Anxiety Copyright 2016 AnxietyHub Medications Specifically for Public Speaking and Social Anxiety This is not intended to

More information

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013 For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013 This power point is only a guideline for recommendations in the treatment of psychiatric disorders. This is not comprehensive. Please

More information

9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded

9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please

More information

Schedule FDA & literature based indications

Schedule FDA & literature based indications Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for

More information

Guide to Psychiatric Medications for Children and Adolescents

Guide to Psychiatric Medications for Children and Adolescents Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists

More information

The Medical Letter. on Drugs and Therapeutics. Usual Adult Hypnotic Dose 1,2 Some Adverse Effects Comments Cost 3

The Medical Letter. on Drugs and Therapeutics. Usual Adult Hypnotic Dose 1,2 Some Adverse Effects Comments Cost 3 The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:

More information

Narcolepsy. Jon R. Doud, MD Pulmonary Physician Midwest Center for Sleep Disorders Aurora, IL

Narcolepsy. Jon R. Doud, MD Pulmonary Physician Midwest Center for Sleep Disorders Aurora, IL Narcolepsy Jon R. Doud, MD Pulmonary Physician Midwest Center for Sleep Disorders Aurora, IL Narcolepsy A central nervous system disorder that is an important cause of persistent sleepiness. The second

More information

Children s Hospital Of Wisconsin

Children s Hospital Of Wisconsin Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,

More information

Psychobiology Handout

Psychobiology Handout Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are

More information

Modern Management of Sleep Disorders

Modern Management of Sleep Disorders Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures Case 68 yr. old WF with >15 yr. of poor sleep Difficulty with both initiation and maintenance

More information

Affective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018

Affective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Dr. Alia Shatanawi March 12, 2018 Affective or Mood Disorders Reactive Depression. Secondary: Medical Neurological Drugs Major (Endogenous) Depression = Unipolar: Depressed

More information

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution

More information

Index. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. sleep.theclinics.com. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Actigraphy, 475, 485, 496 Adolescents, sleep disorders in, 576 578 Adults, sleep disorders in, 578 580 Advanced sleep phase disorder, 482 Age,

More information

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder

More information

Modern Management of Sleep Disorders. If Only I Could Sleep Like I Did Before

Modern Management of Sleep Disorders. If Only I Could Sleep Like I Did Before Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures If Only I Could Sleep Like I Did Before Sleep Case 52 yr. old WF with >4 yr. of poor sleep

More information

PHARMACOLOGY OF SLEEP

PHARMACOLOGY OF SLEEP NAMS REGIONAL SYMPOSIUM ON SLEEP MEDICINE PHARMACOLOGY OF SLEEP DR. K.K. SHARMA Department of Pharmacology School of Medical Sciences & Research (SMSR) Sharda University, Greater Noida- 201306. 1 Introduction

More information

SLEEP AND MELATONIN SECRETION ABNORMALITIES IN CHILDREN & ADOLESCENTS WITH FASD DR. S. GORIL DR. D. ZALAI DR. C. SHAPIRO DR. L. A.

SLEEP AND MELATONIN SECRETION ABNORMALITIES IN CHILDREN & ADOLESCENTS WITH FASD DR. S. GORIL DR. D. ZALAI DR. C. SHAPIRO DR. L. A. SLEEP AND MELATONIN SECRETION ABNORMALITIES IN CHILDREN & ADOLESCENTS WITH FASD DR. S. GORIL DR. D. ZALAI DR. C. SHAPIRO DR. L. A. SCOTT SLEEP Pivotal role in brain development during maturation Sleep

More information

LIBERTY SLEEP ASSOCIATES, LLC SLEEP DISORDERS CENTER

LIBERTY SLEEP ASSOCIATES, LLC SLEEP DISORDERS CENTER SLEEP QUESTIONNAIRE Patient Name: Sex: Age: Date: Occupation: Usual Work Hours/Days: Family Physician (PCP): Ht Wt Neck Size: What was your weight one year ago? Five years ago? Marital status: (circle

More information

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine

More information

Depression & Anxiety in Adolescents

Depression & Anxiety in Adolescents Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with

More information

TOP 10 LIST OF SLEEP QUESTIONS. Kenneth C. Sassower, MD Sleep Disorders Unit Massachusetts General Hospital for Children

TOP 10 LIST OF SLEEP QUESTIONS. Kenneth C. Sassower, MD Sleep Disorders Unit Massachusetts General Hospital for Children TOP 10 LIST OF SLEEP QUESTIONS Kenneth C. Sassower, MD Sleep Disorders Unit Massachusetts General Hospital for Children QUESTION #1: ARE SLEEP ISSUES IN CHILDREN THE SAME AS IN ADULTS? Distinctive Features

More information

TRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE

TRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE TRAZODONE IN INSOMNIA COMORBID WITH DEPRESSION: AN AWAKENING LACK OF STRONG EVIDENCE Gordon Ang, PharmD Central Texas Veterans Health Care System 1/5/2018 1 Abbreviations Abbreviation GERD MDD PTSD PSQI

More information

SLEEP DISORDERS. Kenneth C. Sassower, MD Division of Sleep Medicine; Department of Neurology Massachusetts General Hospital for Children

SLEEP DISORDERS. Kenneth C. Sassower, MD Division of Sleep Medicine; Department of Neurology Massachusetts General Hospital for Children SLEEP DISORDERS Kenneth C. Sassower, MD Division of Sleep Medicine; Department of Neurology Massachusetts General Hospital for Children Distinctive Features of Pediatric Sleep Daytime sleepiness uncommon

More information

Michelle Zetoony, DO, FCCP, FACOI th Avenue S, Suite A Phone: Fax:

Michelle Zetoony, DO, FCCP, FACOI th Avenue S, Suite A Phone: Fax: Michelle Zetoony, DO, FCCP, FACOI 545 4 th Avenue S, Suite A Phone: 727-826-0933 Fax: 727-826-0744 http://www.dosleep.com SLEEP TALK 9/9 BMJ Open2012 Pharmacology and therapeutics Research What is sleep?

More information

Antidepressants Choosing the Right One

Antidepressants Choosing the Right One Antidepressants Choosing the Right One Dr Lim Boon Leng Consultant Psychiatrist Dr BL Lim Centre For Psychological Wellness #09-09, Gleneagles Medical Centre, 6 Napier Rd, S258499 www.psywellness.com.sg

More information

Antidepressant Selection in Primary Care

Antidepressant Selection in Primary Care Antidepressant Selection in Primary Care Rebecca D. Lewis, DO OOA Summer CME Oklahoma City, OK 6 August 2017 Objectives Understand the epidemiology of depression. Recognize factors to help choose antidepressants.

More information

Diana Corzine, MD ABMS Sleep Chief MT VA Sleep Medicine Common Sleep Disorders

Diana Corzine, MD ABMS Sleep Chief MT VA Sleep Medicine Common Sleep Disorders Diana Corzine, MD ABMS Sleep Chief MT VA Sleep Medicine 2018 Common Sleep Disorders Objectives: Understand Understand how Sleep Disorders affects health. Describe Describe some Common Sleep Disorders.

More information

Sleep and Parkinson's Disease

Sleep and Parkinson's Disease Parkinson s Disease Clinic and Research Center University of California, San Francisco 505 Parnassus Ave., Rm. 795-M, Box 0114 San Francisco, CA 94143-0114 (415) 476-9276 http://pdcenter.neurology.ucsf.edu

More information

Earl J. Soileau, MD, FSAHM Asst Professor, Family Medicine LSU HSC Medical School New Orleans at Lake Charles

Earl J. Soileau, MD, FSAHM Asst Professor, Family Medicine LSU HSC Medical School New Orleans at Lake Charles Earl J. Soileau, MD, FSAHM Asst Professor, Family Medicine LSU HSC Medical School New Orleans at Lake Charles Sleep Disorders Restless Legs Syndrome (RLS) and Periodic Limb Movement Disorder (PLMD) Sleep

More information

TREATMENT OF DEPRESSION IN LATE LIFE. Robert Kohn, MD

TREATMENT OF DEPRESSION IN LATE LIFE. Robert Kohn, MD TREATMENT OF DEPRESSION IN LATE LIFE Robert Kohn, MD WHY TREAT ELDERLY PERSONS Major depression is not a normal part of aging The rates are lower than younger cohorts The prevalence rates are still high

More information

Introduction to Drug Treatment

Introduction to Drug Treatment Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical

More information

CPT David Shaha, MC US Army

CPT David Shaha, MC US Army CPT David Shaha, MC US Army None Thoughts and comments are my own and do not represent the official policy of the Department of the Army, Department of Defense, or United States Government. Clinical Case

More information

Insomnia treatment in primary care

Insomnia treatment in primary care Insomnia treatment in primary care Daniel J. Buysse, MD UPMC Professor of Sleep Medicine Professor of Psychiatry and Clinical and Translational Science University of Pittsburgh School of Medicine buyssedj@upmc.edu

More information

This initial discovery led to the creation of two classes of first generation antidepressants:

This initial discovery led to the creation of two classes of first generation antidepressants: Antidepressants - TCAs, MAOIs, SSRIs & SNRIs First generation antidepressants TCAs and MAOIs The discovery of antidepressants could be described as a lucky accident. During the 1950s, while carrying out

More information

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* Bupropion (Wellbutrin) Start: IR-100 mg bid X 4d then to 100 mg tid; SR-150

More information

Addressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling

Addressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling Addressing the Multiple Causes and Lifestyle Impacts of Insomnia: A Guide for Patient Counseling Educational Objectives: At the completion of this knowledge-based activity, participants will be able to:

More information

Sleep Disorders: Assessment and Therapeutic Options

Sleep Disorders: Assessment and Therapeutic Options Sleep Disorders: Assessment and Therapeutic Options John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Professor

More information

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the

More information

Managing Insomnia Disorder A Review of the Research for Adults

Managing Insomnia Disorder A Review of the Research for Adults Managing Insomnia Disorder A Review of the Research for Adults e Is This Information Right for Me? This information is right for you if: Your health care professional said you have insomnia disorder (said

More information

Pharmacological Help for a Good Night s s Sleep. Thomas Owens, MD

Pharmacological Help for a Good Night s s Sleep. Thomas Owens, MD Pharmacological Help for a Good Night s s Sleep Thomas Owens, MD Objectives 1. Define insomnia and characterize the symptoms and array of causes. 2. Describe traditional and new pharmacologic approaches

More information

Sleep disorders. Norbert Kozak

Sleep disorders. Norbert Kozak Sleep disorders Norbert Kozak About the sleep Each of us will spend about 1/3 of our lifetime sleeping....and 1/3 part of the population has sleep complain Sleep is an essential biological function, but

More information

Psychopharmacology of Sleep Disorders

Psychopharmacology of Sleep Disorders Psychopharmacology of Sleep Disorders Matt T. Bianchi MD PhD MMSc Assistant Professor Director, Sleep Division Neurology Department Massachusetts General Hospital Funding and Disclosures Funding: MGH Neurology

More information

The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders What are functional GI disorders?

The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders What are functional GI disorders? The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders Christine B. Dalton, PA-C Douglas A. Drossman, MD and Kellie Bunn, PA-C What are functional GI

More information

Psychopharmacology of Sleep Disorders

Psychopharmacology of Sleep Disorders Psychopharmacology of Sleep Disorders John W. Winkelman MD, PhD Chief, Sleep Disorders Clinical Research Program Departments of Psychiatry and Neurology Massachusetts General Hospital Professor of Psychiatry

More information

Consciousness, Stages of Sleep, & Dreams. Defined:

Consciousness, Stages of Sleep, & Dreams. Defined: Consciousness, Stages of Sleep, & Dreams I. Consciousness Conscious is: Waking Consciousness Defined: Altered State of Consciousness Defined: Most of waking life Fuzzy, organized, bizarre thoughts Examples:

More information

EEG Electrode Placement

EEG Electrode Placement EEG Electrode Placement Classifying EEG brain waves Frequency: the number of oscillations/waves per second, measured in Hertz (Hz) reflects the firing rate of neurons alpha, beta, theta, delta Amplitude:

More information

Common Antidepressant Medications for Adults

Common Antidepressant Medications for Adults (and Citalopram (Celexa) Escitalopram (Lexapro) Fluoxetine (Prozac) Fluoxetine Weekly (Prozac Weekly) 20 in AM w/ food (10 mg in elderly or those w/ panic disorder) 20 40 40 (If age >60yo, max 20) 10 10

More information

Sleep and Insomnia 2/8/2018. Presented by. Marie Rataj, MSN, APRN, ANP. Objectives. Everything you wanted to know

Sleep and Insomnia 2/8/2018. Presented by. Marie Rataj, MSN, APRN, ANP. Objectives. Everything you wanted to know Sleep and Insomnia Everything you wanted to know Presented by Marie Rataj, MSN, APRN, ANP Objectives Develop a basic knowledge of normal sleep and differentiate from abnormal sleep Develop basic understanding

More information

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17

More information

Xartemis XR (oxycodone / acetaminophen extended release)

Xartemis XR (oxycodone / acetaminophen extended release) RATIONALE FOR INCLUSION IN PA PROGRAM Background Xartemis XR is a combination of oxycodone and acetaminophen in a dosage formulation to deliver both immediate pain relief, in less than an hour, and extended-release

More information

New Patient Questionnaire

New Patient Questionnaire 4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with

More information

SLEEP DISORDERS IN HUNTINGTON S DISEASE. Gary L. Dunbar, Ph.D.

SLEEP DISORDERS IN HUNTINGTON S DISEASE. Gary L. Dunbar, Ph.D. SLEEP DISORDERS IN HUNTINGTON S DISEASE Gary L. Dunbar, Ph.D. Executive Director, Field Neurosciences Institute Co-Director, Program in Neuroscience Central Michigan University Pre-Talk Test 1. Which type

More information

OXYCODONE IR (oxycodone)

OXYCODONE IR (oxycodone) RATIONALE FOR INCLUSION IN PA PROGRAM Background Oxycodone hydrochloride, a pure opioid agonist, is used in the treatment of moderate to severe pain (1-2). The precise mechanism of action is unknown; however,

More information

Modern Management of Sleep Disorders. Case. Introduction. Topics Covered. Douglas C. Bauer, MD University of California, San Francisco

Modern Management of Sleep Disorders. Case. Introduction. Topics Covered. Douglas C. Bauer, MD University of California, San Francisco Modern Management of Sleep Disorders Douglas C. Bauer, MD University of California, San Francisco No Disclosures Case 68 yr. old WF with >15 yr. of poor sleep Difficulty with both initiation and maintenance

More information

Mentoring Session: Participant Cases

Mentoring Session: Participant Cases Handout for the Neuroscience Education Institute (NEI) online activity: Mentoring Session: Participant Cases The Case: 55-year-old patient with depression and anxiety The Question: What to do when antidepressants

More information

Psychiatry curbside: Answers to a primary care doctor s top mental health questions

Psychiatry curbside: Answers to a primary care doctor s top mental health questions Psychiatry curbside: Answers to a primary care doctor s top mental health questions April 27, 2018 Laurel Ralston, DO Psychiatrist, Taussig Cancer Institute Objectives Review current diagnostic and prescribing

More information

The Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD

The Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD The Benefits and Limitations of Medication Treatment for Executive Dysfunctions and ADHD Damon Korb, MD Behavioral and Developmental Pediatrician Director of the Center for Developing Minds Los Gatos,

More information

A Review of Sleep Disorders in Cancer Patients: Finding the Dream Treatment

A Review of Sleep Disorders in Cancer Patients: Finding the Dream Treatment A Review of Sleep Disorders in Cancer Patients: Finding the Dream Treatment Jordan Pleskow, PharmD Roswell Park Cancer Institute Oncology Symposium 11/11/17 Objectives Evaluate the issues with sleep in

More information

Psychiatric Treatment of the Concussed Athlete

Psychiatric Treatment of the Concussed Athlete Psychiatric Treatment of the Concussed Athlete Eastern Athletic Trainers Association January 11 th, 2015 Alexander S. Strauss, MD Centra, P.C. E-MAIL: DRSTRAUSS@ALEXSTRAUSSMD.COM Evidence Mounts Linking

More information

90 dosage units per 90 days OR. Extended-release Formulations Ultram ER 90 dosage units per 90 days OR

90 dosage units per 90 days OR. Extended-release Formulations Ultram ER 90 dosage units per 90 days OR Pre - PA Allowance 12 years of age or older Quantity Immediate-release Formulation Ultracet 720 dosage units per 90 days OR Ultram 720 dosage units per 90 days Extended-release Formulations Ultram ER 90

More information

Antidepressant Selection in Primary Care

Antidepressant Selection in Primary Care Antidepressant Selection in Primary Care R E B E C C A D. L E W I S, D O O O A S U M M E R C M E B R A N S O N, M O 1 5 A U G U S T 2 0 1 5 Objectives Understand the epidemiology of depression. Recognize

More information

Linda Sobeski Farho, PharmD, BCPS Assistant Professor, Pharmacy Practice UNMC College of Pharmacy Critical Issues in Geriatrics June 24, 2010

Linda Sobeski Farho, PharmD, BCPS Assistant Professor, Pharmacy Practice UNMC College of Pharmacy Critical Issues in Geriatrics June 24, 2010 Pharmacologic Treatment of Depression Linda Sobeski Farho, PharmD, BCPS Assistant Professor, Pharmacy Practice UNMC College of Pharmacy Critical Issues in Geriatrics June 24, 2010 1 Disclosure I have no

More information

Overview. Surviving shift work. What is the circadian rhythm? Components of a Generic Biological Timing System 31/10/2017

Overview. Surviving shift work. What is the circadian rhythm? Components of a Generic Biological Timing System 31/10/2017 Overview Surviving shift work Dr Claire M. Ellender Respiratory and Sleep Physician Princess Alexandra Hospital Conflicts nil relevant Circadian rhythm Impacts of shift work on health Case example Circadian

More information

Insomnia. Learning Objectives. Disclosure 6/7/11. Research funding: NIH, Respironics, Embla Consulting: Elsevier

Insomnia. Learning Objectives. Disclosure 6/7/11. Research funding: NIH, Respironics, Embla Consulting: Elsevier Insomnia Teofilo Lee-Chiong MD Professor of Medicine National Jewish Health University of Colorado Denver School of Medicine Learning Objectives Learn about the causes of transient and chronic Learn how

More information

ANTIDEPRESSANT MEDICATION & RISK OF DEMENTIA

ANTIDEPRESSANT MEDICATION & RISK OF DEMENTIA ANTIDEPRESSANT MEDICATION & RISK OF DEMENTIA A Nationwide Cohort Study in Taiwan / Speaker: Chee-Kin Then / Advisor: Prof. Shing-Chuan Shen / Unit: Graduate Institute of Medical Sciences / Date: 2017.04.

More information

Sleep Wake Cycle in Depression

Sleep Wake Cycle in Depression Sleep Wake Cycle in Depression Constantin R. Soldatos Professor of Psychiatry & Founder of Sleep Study Center Eginition Hospital University of Athens Lecture in Suzdal School, 20/04/2013 SLEEP WAKE CYCLE

More information

Anxiety Disorders- OCD. Peter Giacobbe MD FRCPC L. Ravindran MD FRCPC

Anxiety Disorders- OCD. Peter Giacobbe MD FRCPC L. Ravindran MD FRCPC Anxiety Disorders- OCD Peter Giacobbe MD FRCPC L. Ravindran MD FRCPC Anxiety Disorders - Epidemiology Anxiety disorders are the most common class of mental disorders Estimated lifetime prevalence rates

More information